Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Leukemia

Free Subscription 02.03.2026 5 Ann Hematol 2 Blood 1 Cancer 1 Clin Infect Dis 1 Eur J Haematol 1 Exp Hematol 1 Int J Hematol 2 J Pediatr Hematol Oncol 4 Leuk Lymphoma 2 Leukemia 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Hematol

1. ONCUL Y, Akyay A, Macit B, Ozgen U, et al
   Treatment Outcomes and Factors Affecting Survival in Pediatric Acute Myeloid Leukemia.
   Ann Hematol. 2026;105:141.
   PubMed         Abstract available
   
   
2. PAN Y, Shen Y, Miao S, Yao C, et al
   The impact of venetoclax treatment duration on efficacy and hematologic toxicity in acute myeloid leukemia: a systematic review and meta-analysis.
   Ann Hematol. 2026;105:139.
   PubMed         Abstract available
   
   
3. ATEF B, El-Ashwah S, Saleh LM, Gawish H, et al
   Potential utility of PPARgamma agonists in targeting chronic myeloid leukemia stem cells.
   Ann Hematol. 2026;105:136.
   PubMed         Abstract available
   
   
4. EFENDI ERDEM E, Cecener G, Unal U, Tezcan Unlu H, et al
   Identification of the Philadelphia-like subgroup in Turkish pediatric patients with acute lymphoblastic leukemia.
   Ann Hematol. 2026;105:138.
   PubMed         Abstract available
   
   
5. SHELIKHOVA L, Ilyushina M, Khismatullina R, Balashov D, et al
   Long-term outcome of children with acute lymphoblastic leukemia after hematopoietic stem cell transplantation based on ex-vivo alpha-beta T cell depletion.
   Ann Hematol. 2026;105:135.
   PubMed         Abstract available
   
   

   
   Blood

6. PARFENOVA EN, Vrdoljak N, Mosca D, Aristizabal-Henao JJ, et al
   Targeting ABCD1 inhibits peroxisomal fatty acid oxidation to selectively eliminate acute myeloid leukemia cells.
   Blood. 2026 Feb 26:blood.2025031202. doi: 10.1182/blood.2025031202.
   PubMed         Abstract available
   
   
7. HIMONAS E, de Beauchamp L, Zerbst D, Desmares-Romain E, et al
   A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.
   Blood. 2026 Feb 24:blood.2024027853. doi: 10.1182/blood.2024027853.
   PubMed         Abstract available
   
   

   
   Cancer

8. 
   Correction to "Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia".
   Cancer. 2026;132:e70325.
   PubMed        
   
   

   
   Clin Infect Dis

9. SILLAT MS, Chacko G, Jennifer L
   Intracranial Lesion in a Patient With Chronic Myeloid Leukemia.
   Clin Infect Dis. 2026;82:354-357.
   PubMed         Abstract available
   
   

   
   Eur J Haematol

10. GAIDANO G, Danesi R
    Acalabrutinib in Chronic Lymphocytic Leukemia: Pharmacology and Emerging Clinical Perspectives.
    Eur J Haematol. 2026 Feb 24. doi: 10.1111/ejh.70144.
    PubMed         Abstract available
    
    

    
    Exp Hematol

11. KHAN AB, Huntly BJP
    Taking the direct route: menin inhibitors go straight to the frontline in KMT2A-rearranged acute leukemia.
    Exp Hematol. 2026 Feb 4:105386. doi: 10.1016/j.exphem.2026.105386.
    PubMed         Abstract available
    
    

    
    Int J Hematol

12. MIYAZAKI Y, Matsumura I, Arita T, Fukuda R, et al
    Post-marketing surveillance of quizartinib for relapsed or refractory FLT3-ITD-positive acute myeloid leukemia in Japan.
    Int J Hematol. 2026 Feb 26. doi: 10.1007/s12185-026-04181.
    PubMed         Abstract available
    
    

    
    J Pediatr Hematol Oncol

13. 
    Isolated Anterior Segment Relapse in a Child With B-cell Precursor Acute Lymphoblastic Leukemia: A Rare Case Report: ERRATUM.
    J Pediatr Hematol Oncol. 2026;48:e117.
    PubMed        
    
    
14. YANG W, Qin M, Jia C, Zhu G, et al
    Allogeneic Hematopoietic Stem Cell Transplantation for Children With Mixed Phenotype Acute Leukemia: A Single-Center Retrospective Study.
    J Pediatr Hematol Oncol. 2026;48:e69-e77.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

15. TIAN JX, Liao YX, Wang XX, Wang XD, et al
    Olverembatinib and high-dose methotrexate in acute lymphoblastic leukemia: delayed methotrexate clearance and increased nephrotoxicity.
    Leuk Lymphoma. 2026 Feb 25:1-7. doi: 10.1080/10428194.2026.2634179.
    PubMed         Abstract available
    
    
16. REDDY NALLA A, Ganesan K, Muthukumar V, Seshadri N, et al
    Short, safe, and sustainable: outpatient blinatumomab as a bridge and beyond in children with pre B-acute lymphoblastic leukemia.
    Leuk Lymphoma. 2026 Feb 24:1-3. doi: 10.1080/10428194.2026.2634943.
    PubMed        
    
    
17. MAQBOOL S, Rehman MEU, Khan I, Ibrahim M, et al
    Survival disparities in Philadelphia chromosome-positive vs. Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in the era of modern therapeutic approaches: a decade-long surveillance, epidemiology, and end results (SEER) data based
    Leuk Lymphoma. 2026 Feb 23:1-8. doi: 10.1080/10428194.2026.2621822.
    PubMed         Abstract available
    
    
18. OHNO H, Maekawa F, Hayashida M, Nakagawa M, et al
    t(14;19)(q32;q13) breakpoints telomeric to BCL3 on 19q13.32 in B-cell lymphomas other than chronic lymphocytic leukemia and long-range structures of der(19)t(14;19) based on optical genome mapping.
    Leuk Lymphoma. 2026 Feb 22:1-11. doi: 10.1080/10428194.2026.2633186.
    PubMed         Abstract available
    
    

    
    Leukemia

19. BOHRA A, Hassan R, Zanwar S, Jevremovic D, et al
    Correction: Peripheral blood flow cytometry-based definition of plasma cell leukemia.
    Leukemia. 2026 Feb 25. doi: 10.1038/s41375-026-02897.
    PubMed        
    
    
20. LECORNEC N, Rabian F, Dourthe ME, Chevillon F, et al
    Characteristics and outcome determinants in children, adolescents and young adults who failed tisagenlecleucel for B-cell acute lymphoblastic leukemia.
    Leukemia. 2026 Feb 24. doi: 10.1038/s41375-026-02867.
    PubMed         Abstract available
    
    

    
    PLoS One

21. TIRADO HA, Balasundaram N, Jacobs J, Leguay F, et al
    The EAAT1 aspartate/glutamate transporter is dispensable for acute myeloid leukemia cell growth and response to therapy.
    PLoS One. 2026;21:e0329048.
    PubMed         Abstract available
    
    
22. TERCAN B
    Robust predictors for drug response of patients with acute myeloid leukemia.
    PLoS One. 2026;21:e0343422.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum